|
Re: NASH is a $35 Billion US/year market
|
2
|
Resverlogix Corp.
|
Dec 31, 2018 10:21AM
|
|
Symposium tomorrow
|
2
|
Resverlogix Corp.
|
Aug 30, 2019 01:25PM
|
|
Re: Now the webcast is up
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 01:56PM
|
|
Re: Can Hepalink afford US rights? and ROFR
|
2
|
Resverlogix Corp.
|
Feb 04, 2019 04:25PM
|
|
Will we see 5 point MACE reduction results in BETONMACE
|
2
|
Resverlogix Corp.
|
Jun 15, 2019 09:17AM
|
|
Re: 3 point MACE vs 5 point MACE
|
2
|
Resverlogix Corp.
|
Nov 02, 2018 11:18AM
|
|
Re: Tundup's message
|
2
|
Resverlogix Corp.
|
Apr 14, 2019 07:02AM
|
|
Re: Well here we are....
|
2
|
Resverlogix Corp.
|
Jan 31, 2019 10:32AM
|
|
Re: Possible Zenith deal,..
|
2
|
Resverlogix Corp.
|
Nov 17, 2018 03:12PM
|
|
Re: Zenith and Pfizer collaboration news
|
2
|
Resverlogix Corp.
|
Nov 20, 2018 09:47AM
|
|
Re: Clarification on BETonMACE baseline data
|
2
|
Resverlogix Corp.
|
Sep 06, 2019 02:09AM
|
|
Re: Welcome to the Resverlogix Lunch Counter, January special is the nothingburger...
|
2
|
Resverlogix Corp.
|
Jan 23, 2019 06:33PM
|
|
Re: Placebo rate now that 250 MACE has been reached
|
2
|
Resverlogix Corp.
|
Jun 11, 2019 10:04AM
|
|
Re: Video on BET inhibition in renal and cardiovascular disease
|
2
|
Resverlogix Corp.
|
Sep 24, 2019 12:42PM
|
|
Re: What impact would a PR like this have?
|
2
|
Resverlogix Corp.
|
Jan 29, 2019 04:03PM
|
|
Re: Draft of my SA blog post, comments please.
|
2
|
Resverlogix Corp.
|
Mar 25, 2019 06:10PM
|
|
Re: If BP buys Apabetalone,...
|
2
|
Resverlogix Corp.
|
Nov 05, 2019 03:20PM
|
|
Re: Collection of ERA-EDTA and ESC Resverlogix Sponsored Symposia Videos
|
2
|
Resverlogix Corp.
|
Sep 26, 2019 11:40AM
|
|
Re: Volume almost 100,000 at 11am
|
2
|
Resverlogix Corp.
|
Mar 13, 2019 03:25PM
|
|
Re: General chances of success
|
2
|
Resverlogix Corp.
|
Feb 06, 2019 10:20AM
|
